Problems and strategies in clinical application of associating liver partition and portal vein ligation for staged hepatectomy.
10.3760/cma.j.cn112139-20200218-00094
- Author:
Sadula ABUDUHAIBAIER
1
;
Si-Qian REN
1
;
Chunhui YUAN
1
;
Dianrong XIU
1
Author Information
1. Department of General Surgery, Peking University Third Hospital, Beijing 100191, China.
- Publication Type:Journal Article
- Keywords:
Associating liver partition and portal vein ligation for staged hepatectomy;
Hepatectomy;
Liver neoplasms
- MeSH:
Embolization, Therapeutic;
Hepatectomy/methods*;
Humans;
Ligation;
Liver/surgery*;
Liver Neoplasms/surgery*;
Liver Regeneration;
Portal Vein/surgery*;
Treatment Outcome
- From:
Chinese Journal of Surgery
2020;58(11):835-840
- CountryChina
- Language:Chinese
-
Abstract:
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can speed up the regeneration of future liver remnant (FLR) in short period of time, and offer a chance for surgical resection for patients without sufficient FLR. However, ALPPS still remains controversy due to its high perioperative morbidity and mortality, as well as the uncertain long-term oncological benefits. How to solve these problems is the key to ensure the safety of surgery.This article focus on the indication selection, liver function reserve evaluation and timing to perform the second stage surgery, surgical mode evolution and comparison with portal venous embolization/portal venous ligation+two-stage hepatectomy.
